Phase 1 Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any sex
- People with a documented history of moderate to severe eczema (atopic dermatitis) that has lasted for at least 1 year
- People whose eczema has not responded well enough to prescription steroid creams or other prescribed topical treatments used consistently
- People who are willing to apply a simple, fragrance-free moisturising lotion twice a day for at least 7 days before the first study visit
- People who are able and willing to attend clinic visits and follow the study procedures
- People who are able to read, understand, and sign a consent form
Who may not be able to join:
- People whose blood test results show abnormalities in areas such as red blood cell levels, white blood cell levels, platelets, certain liver measures, kidney function, or muscle enzyme levels
- People who test positive for hepatitis B or hepatitis C
- People who have another active skin condition that could be confused with eczema
- People who have previously taken part in another clinical trial using an experimental treatment, or who are currently enrolled in another clinical study
- People with serious ongoing or past illness affecting the heart, kidneys, nervous system, hormones, metabolism, or lymphatic system, or any other condition that could interfere with safe participation
- People who have used prescription steroid creams or other prescribed topical eczema treatments within 1 week before the first study visit
- People with a known history of HIV infection
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-301-540-2600
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of treatment-emergent adverse events (TEAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.